Watchlist

Watchlist
Abbott Laboratories (ABT)
Abbott Laboratories (ABT)
Abbott Hosts Conference Call for Fourth-Quarter Earnings
ABBOTT PARK, Ill., Dec. 18, 2017 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its fourth-quarter 2017 financial results on Wednesday, Jan. 24, 2018 , before the market opens. The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Centra…
Abbott raising quarterly dividend
Abbott Laboratories (NYSE: ABT ) declares $0.28/share quarterly dividend , 5.7% increase from prior dividend of $0.265. More news on: Abbott Laboratories, Dividend news, Read more …
Abbott Raising Quarterly Dividend for 46th Straight Year
ABBOTT PARK, Ill., Dec. 15, 2017 /PRNewswire/ --The board of directors of Abbott (NYSE: ABT) today increased the company's quarterly common dividend to 28 cents per share from 26.5 cents per share. This marks the 376 th consecutive quarterly dividend to be paid by Abbott since…
The Next 20 Dividend Achievers Absolutely Trounce The Market
In April of 2015, I skimmed 15 of the largest cap Dividend Achievers ( VIG ). Of course, the index is available in ETF form thanks to Vanguard. Here are the 15 Achievers that I skimmed and purchased in 2015: Nike (NYSE: NKE ), CVS (NYSE: CVS ), Walgreens (NASDAQ: WBA ), Microsoft (NASDAQ: MS…
Your Daily Pharma Scoop: Right Time To Buy Regeneron, Eli Lilly Gives Guidance, Bluebird Announces Offering
Content Analysis of coverage: REGN Stocks in the news: LLY, SNY, BLUE Analyst Ratings Insider Sales Insider Purchases Earnings Report Secondary Offerings Earnings Calendar Trade Idea of the Day (for TPT subscribers only) Subscriber Questions & An…
I'm Sticking With CVS And Walgreens, My Last Two Losers
In April of 2015 I skimmed 15 of the largest cap Dividend Achievers. The Portfolio consists of the following 15 companies. Nike (NYSE: NKE ), CVS (NYSE: CVS ), Walgreens (NASDAQ: WBA ), Microsoft (NASDAQ: MSFT ), 3M (NYSE: MMM ), Colgate-Palmolive (NYSE: CL ), Johnson & Johnson (NYSE: JNJ …
Premarket analyst action - healthcare
MyoKardia (NASDAQ: MYOK ) initiated with Overweight rating and $54 (37% upside) price target by JPMorgan. More news on: MyoKardia, Impax Laboratories, Inc., Endo International plc, Healthcare stocks news, Stocks on the move, Read more …
Dividend Income Update November 2017
The beginning of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated. No doubt, these are the best posts to write and read online as it only provides further proof that dividend invest…
Your Daily Pharma Scoop: Loxo Data, GW Pharmaceuticals' Q4 Results, Zynerba Positive Data
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Total Pharma Tracker subscribers get the full version with actionable ideas one …
My Dividend Growth Portfolio Update - 48 Holdings, 1 Buy
Introduction Welcome to my monthly portfolio review covering all of the activity over the past month. This series of articles documents my journey as a young father of two towards my eventual retirement. The goal of my portfolio is to generate a growing income stream for my wife and me durin…
Abbott Laboratories (ABT)